Scope Fluidics Spolka AkcyjnaWAR:SCP +0.17%49 Days Inventory is 772.10 as of Mar. 2026, which is 358% above its 10-year median of 168.56. GuruFocus rates WAR:SCP with a GF Score™ of 49/100 and a GF Value™ of zł129.79 (Fairly Valued). The stock has 4 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, Scope Fluidics Spolka Akcyjna ranks worse than 94.94% on this metric.
The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Days Inventory or its related term are showing as below:
WAR:SCP'
s Days Inventory Range Over the Past 10 Years
Min: 122.09 Med: 168.56 Max: 368.91
Current: 367.23
During the past 10 years, Scope Fluidics Spolka Akcyjna's highest Days Inventory was 368.91. The lowest was 122.09. And the median was 168.56.
WAR:SCP's Days Inventory is ranked worse than 94.94% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs WAR:SCP: 367.23
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Scope Fluidics Spolka Akcyjna's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Scope Fluidics Spolka Akcyjna's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 247.57.
Scope Fluidics Spolka Akcyjna (WAR:SCP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Scope Fluidics Spolka Akcyjna's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Scope Fluidics Spolka Akcyjna's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Scope Fluidics Spolka Akcyjna Days Inventory Related Terms
Scope Fluidics Spolka Akcyjna Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scope Fluidics Spolka Akcyjna Days Inventory Chart
WAR:SCP vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scope Fluidics Spolka Akcyjna Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Days Inventory distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Days Inventory of 772.10 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. This is 358% above median its historical median of 168.56. Over the past decade, Scope Fluidics Spolka Akcyjna's Days Inventory has ranged from 122.09 to 368.91. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #169 out of 178 companies in the Medical Diagnostics & Research industry, placing it in the top 94.9%.
Is Scope Fluidics Spolka Akcyjna's Days Inventory too high?
Scope Fluidics Spolka Akcyjna's current Days Inventory of 772.10 is 358% above median its 10-year median of 168.56. Over the past 10 years, this metric has ranged from a low of 122.09 to a high of 368.91. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Scope Fluidics Spolka Akcyjna's value of 772.10 is 1020.9% above this industry median. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #169 out of 178 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #169 out of 178 companies for Days Inventory. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. The industry median Days Inventory is 68.88. Scope Fluidics Spolka Akcyjna's value of 772.10 is 1020.9% above this benchmark. Historically, Scope Fluidics Spolka Akcyjna's own Days Inventory has ranged from 122.09 to 368.91 over the past decade. While the company's 10-year median is 168.56 vs. the industry median of 68.88, Scope Fluidics Spolka Akcyjna has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scope Fluidics Spolka Akcyjna's current Days Inventory of 772.10 is 1020.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current Days Inventory is 772.10, which is 358% above median its own 10-year median of 168.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł129.79, compared to a current price of zł120.20 — trading 7.4% below its estimated fair value. The current Days Inventory is 772.10, which is 358% above median its 10-year median of 168.56 and 1020.9% above the Medical Diagnostics & Research industry median of 68.88. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Days Inventory is 772.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued.
The current stock price of zł120.20 is trading 7.4% below its estimated GF Value™ of zł129.79.
GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.
Key valuation signals for WAR:SCP:
Days Inventory: 772.10 (358% above median its 10-year median of 168.56)
GF Value™: zł129.79 vs. price of zł120.20 (7.4% below fair value)
Industry Position: 1020.9% above the Medical Diagnostics & Research median (#169 of 178)
No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scope Fluidics Spolka Akcyjna Business Description
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
49GF Score
Get the complete analysis for WAR:SCP
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SCP has been successfully added to your 
